Plitidepsin Under Clinical Trial for COVID-19

Abstract

Respected Editor, Our team wants to draw attention to the clinical trial of the drug Plitidepsin for COVID-19 treatment. SARS-CoV-2 has caused a catastrophe worldwide devastatingly of over 208 million confirmed cases and more than 4.4 million deaths reported worldwide as of early September 2021 according to WHO. Despite of being the only approved antiviral drug for the specific treatment of COVID-19 i.e. Remdesivir, has limited efficacy against the virus [1]. Because of very limited options for treatment, scientists have to work hard to find out more treatment options to protect humanity from the next pandemic.